Altshuler Shaham LTD Charles River Laboratories International, Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $45,679 - $58,328	-130 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $4,844 - $5,957	-13 Reduced 9.09%	130 $54,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $42,066 - $53,145	143 New	143 $53,000
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $38,449 - $46,119	-154 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $6,438 - $7,325	29 Added 23.2%	154 $38,000
Q3 2020 Nov 10, 2020	BUY	$175.56 - $226.45 $21,945 - $28,306	125 New	125 $28,000
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $10,220 - $16,315	-86 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $8,505 - $15,337	86 New	86 $11,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.